.png)
![Ozempic and Wegovy increase risk of thyroid cancer. “Use of GLP-1 RA for 1-3 years was associated with increased risk of all thyroid cancer (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95)](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3139055092816828788)
★★★★★ 4
What a spicy lovely tale of love
Format: Kindle
I receive an ARC copy and am leaving my thoughts voluntarily.
I really liked all the other books in this series and it was so nice to see characters I loved again while being introduced to some new faces that I can to love just as much. And I love seeing that some development has occurred! It’s not vital to the story but still nice to see.
The idea of a romance with one character being a single mom isn’t something I see too often. And it’s done so well here. There’s genuine interest in not only the mom but the child as well and becoming a true family, with all feelings considered. I adored seeing the interactions with Theo. And one character is also trans, with some societal pushback they have to struggle though, which makes life all the harder and the sweet scenes all the sweeter.
The spice here is high. But the thing I love about all Dani’s books is the strong emphasis on consent. It’s not there as an afterthought, it is as important as aspect as the physical act! And I adore it. Anyone that argues consent can’t be sexy should read Dani’s books.
The world building is woven into the plot with exploration of history, discussion of the “he said, she said” of historical events, and how knowing the truth is important. I loved seeing the characters uncover and process everything.
That’s probably a huge trait of Dani’s books I adore—there’s room to breathe. They give you the space to really process which adds to the realism. These are character driven books and I love getting to know each one.
Recommend this one and all the ones before it! Just make sure you can handle the spice and the nastiness of how cruel people can be because it pulls no punches.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 14, 2024
